Investor in companies that develop pharmaceuticals. The company identifies, invests in and accompanies innovative early and mid-stage companies in areas such as immunotherapy, cancer, metabolism, microbiome, CNS, autoimmune diseases, orphan diseases and drug delivery platforms.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Arkin Bio-Ventures‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Pini Orbach Ph.D | Manager |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Arkin Bio-Ventures‘s full profile, request access.
Request a free trialCompany Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 000000000 | 24-Dec-2020 | 00000 00000 00 | 0000 | Drug Discovery | |
00000 000000000000 | 16-Dec-2020 | 0000 00000 | 000.00 | Drug Discovery | |
00000000 | 02-Dec-2020 | 00000 00000 00 | 0000 | Drug Discovery | 0000 000000 00.0 |
00000 000000000000 | 04-Mar-2020 | 00000 00000 00 | 0000 | Biotechnology | |
Oncorus | 20-Dec-2019 | Early Stage VC | 000.00 | Drug Discovery |
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000000 | 20-Dec-2019 | 00000 00000 00 | 000.00 | Completed |
|
00000000 | 04-Jan-2017 | 00000 00000 00 | 00.00 | Completed |
|
0000000 | 15-Dec-2016 | 00000 00000 00 | 000.00 | Completed |
|
Oncorus | 19-Jul-2016 | Early Stage VC | 000.00 | Completed |
|